Skip to main content
MedMen Enterprises Inc. logo

MedMen Enterprises Inc. — Investor Relations & Filings

Ticker · MMNFQ ISIN · CA58507M1077 LEI · 254900FFBPONQV04RD14 CSE Wholesale and retail trade
Open in API
Filings indexed 518 across all filing types
Latest filing 2021-02-09 Capital/Financing Update
Country CA Canada
Listing CSE MMNFQ

About MedMen Enterprises Inc.

https://medmen.com/

MedMen Enterprises Inc. is a cannabis retailer that historically operated dispensaries and cultivation facilities across key U.S. markets, including California, Nevada, Illinois, Massachusetts, and New York. The company focused on delivering a modern, high-end retail experience, offering a curated selection of cannabis products such as flower, pre-rolls, vapes, edibles, concentrates, and CBD wellness items. Its business model emphasized transparency, knowledgeable staff, and seamless online ordering with in-store pickup. As of May 2024, MedMen Enterprises Inc. has filed for bankruptcy and initiated receivership proceedings in California.

Recent filings

Filing Released Lang Actions
Material contracts - Credit agreements.PDF
Capital/Financing Update Classification · 95% confidence The document is titled 'Third Amended and Restated Securities Purchase Agreement' and contains detailed contractual provisions related to the sale of securities, representations and warranties, covenants, events of default, and collateral agent duties. It is a legal agreement concerning financing and securities purchase, not a financial report or regulatory filing. The content is consistent with a capital or financing update, specifically a securities purchase agreement which is a financing transaction document. It is not an announcement or summary but the full agreement text, indicating it is a primary document related to capital raising or financing activities.
2021-02-09 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that MedMen Enterprises Inc. has retained Moelis & Company LLC as a financial advisor to explore strategic alternatives. It does not contain any financial statements, detailed financial results, or regulatory filings. The content focuses on a capital advisory engagement, which relates to financing and strategic positioning. The document length is short (1787 characters), and it is an announcement rather than a report or detailed financial disclosure. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2021-02-09 English
Other.pdf
Regulatory Filings Classification · 95% confidence The document is an Amendment No. 5 to a Form 10 registration statement filed with the SEC, which is a general form for registration of securities under the Securities Exchange Act of 1934. It includes an explanatory note about filing exhibits, a detailed exhibit list, and signatures. The content is regulatory in nature, related to securities registration and amendments, not a financial report or earnings release. It also contains severance agreements as exhibits, which are part of the filing but do not constitute a management or remuneration report by themselves. The document is not a report itself but an amendment filing with exhibits. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory documents that do not fit other specific categories.
2021-02-08 English
Other.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'AMENDMENT NO. 4 TO FORM 10' filed with the United States SEC. Form 10 is a general form for registration of securities pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934. The text includes detailed disclosures about the company, its business, risk factors, financial information, properties, management, legal proceedings, and financial statements. It also references compliance with Exchange Act reporting requirements such as Form 10-K, 10-Q, and 8-K. The length of the document (15,000 characters) and the detailed content including financial statements and supplementary data indicate this is a comprehensive regulatory filing. Form 10 is a registration statement, not an annual report or earnings release. It is a regulatory filing that registers securities and provides extensive company information. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement and does not fit the other more specific categories like Annual Report (10-K) or Earnings Release (ER).
2021-02-08 English
News release - English.pdf
Earnings Release Classification · 95% confidence The document is a short announcement stating that MedMen will release its second quarter fiscal 2021 financial results on a future date (February 16, 2021). It also mentions a conference call to discuss these results. The document does not contain any actual financial data or detailed financial statements. It is primarily an announcement of an upcoming earnings release and conference call, not the earnings release itself or a detailed report. The document length is only 1969 characters, which is quite short and consistent with an announcement rather than a full report. Therefore, this document fits best into the category of Earnings Release (ER) announcement, as it is announcing the upcoming release of quarterly financial results and the related conference call. Q2 2021
2021-02-03 English
Other.pdf
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filing submitted to the SEC, which is a current report used to announce major events that shareholders should know about. The text includes detailed information about a material definitive agreement related to a convertible credit facility amendment, issuance of convertible notes, warrants, and related financial obligations. It also includes references to unregistered sales of equity securities, regulation FD disclosure, and other events. The document is not a full annual or quarterly report, nor is it a transcript, proxy, or governance document. It is a regulatory filing reporting significant financial and corporate events as required by the SEC. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement or a report publication announcement but a substantive regulatory filing.
2021-01-18 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.